# Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA

> **NCT06566482** · PHASE4 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Surgery
- Dexmedetomidine
- Esketamine
- Postoperative Sleep Quality

## Interventions

- **DRUG:** Dexmedetomidine-esketamine combination
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06566482
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-11
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566482, "Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06566482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*